WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

European Medicines Agency recommends restricted use of nimesulide-containing medicinal products

Details
Research
30 September 2007
European Medicines Agency (EMEA)Finalising a review of the liver safety of systemic formulations of medicines containing nimesulide, the European Medicines Agency (EMEA) has concluded that the benefits of these medicines outweigh their risks, but that there is a need to limit the duration of use and to restrict their use to ensure that the risk of patients developing liver problems is kept to a minimum.
Read more ...

New EU Project to Develop a Novel Pandemic Influenza Vaccine

Details
Research
28 September 2007
EUInternational experts in the field of human virus research and vaccine development have teamed up to develop a pandemic influenza vaccine. The aim of the EU-funded FluVac project is to conduct research and development (R&D) into a novel pandemic influenza vaccine that could be used as a potential emergency vaccination. The project partners, recently awarded a grant of €3.5 million under the EU's Sixth Framework Programme (FP6), plan to deliver a prototype vaccine within four years.
Read more ...

Launch of a broad public debate on the future of pharmaceuticals for human use in Europe

Details
Research
26 September 2007
EUThe Commission launches a public consultation on the future of pharmaceuticals for human use in Europe. The pharmaceutical sector has been and remains a key strategic sector in Europe. The future of this sector is a crucial matter for the EU.
Read more ...

Scientists discover how brain regulates fat metabolism

Details
Research
25 September 2007
Scientists have discovered the brain region which controls whether excess energy should be stored as fat or burned in our muscles. The researchers hope that their findings will lead to the development of new treatments for obesity. The work, which was partly funded by the EU, is published in the Journal of Clinical Investigation.
Read more ...

New Awards Program Focused on Cardiovascular Risk in Patients with Diabetes

Details
Research
21 September 2007
PfizerPfizer and the European Foundation for the Study of Diabetes (EFSD) announced today, at the European Association for the Study of Diabetes (EASD) Annual Meeting, the development of a new awards program which will provide research grants to support European research around understanding and reducing cardiovascular risk in patients with diabetes.
Read more ...

ASCO Journals to be accessible through SIMID® S.M.I.L.E.

Details
Research
20 September 2007
SIMID® announced that the American Society of Clinical Oncology (ASCO) has agreed to provide metadata and full-text articles from its portfolio of medical journals through the SIMID Scientific Medical Information Library Europe (S.M.I.L.E.) database.
Read more ...

The Bill & Melinda Gates Foundation New Grants to Fight Tuberculosis Epidemic

Details
Research
20 September 2007
The Bill & Melinda Gates Foundation announced grants totaling $280 million to help fight tuberculosis, an epidemic that infects one-third of people on earth and kills nearly 2 million yearly - mostly in the poorest countries. The 11 new grants will speed research and development on promising vaccines, diagnostic tests, and treatments to help reduce the global TB burden.
Read more ...

More Pharma News ...

  1. Spending on Cancer Research in Europe Rising
  2. semgine GmbH - Product release of the semgine sciPlorer® 1.3
  3. ePharma Physician® Research Study and Advisory Service Focused on Physician IT Adoption
  4. Advances in Functional Proteomics Spell Speedier Drug Discovery
  5. Scientists Shed Light on Blood Sugar Regulation
  6. Screen and Stage Legend Phylicia Rashad Launches a Campaign Close to Her Heart
  7. European Commission Launches Consultation on Pharmaceuticals
  • Start
  • Prev
  • 258
  • 259
  • 260
  • 261
  • 262
  • 263
  • 264
  • 265
  • 266
  • 267
  • Next
  • End
Build the future of health through collaboration & innovation

Business & Industry

  • Novartis signs initial agreement with CureVac to manufacture COVID-19 vaccine candidate
  • AstraZeneca advances mass global rollout of COVID-19 vaccine through COVAX
  • Abbott researchers find rare group of people with controlled HIV who could be a key to unlocking cure
  • Pfizer and BioNTech initiate a study as part of broad development plan to evaluate COVID-19 booster and new vaccine variants
  • Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate

Research & Development

  • New evidence COVID-19 antibodies, vaccines less effective against variants
  • Vaccine development software shows promise in influenza effort, could help defeat coronavirus
  • Researchers discover SARS-CoV-2 inhibitors
  • Nanoparticle-delivered COVID-19 vaccine candidate shows promise in preclinical studies
  • First COVID-19 COVAX vaccine doses administered in Africa
  • Assessing a compound's activity, not just its structure, could accelerate drug discovery
  • Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients

Conferences & Events

  • Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
  • CPhI Worldwide to return in 2021
  • Reuters Events' Cell & Gene Therapy USA
  • Total health: Build a better healthcare system
  • Don't fall for the 'next best action' trap
  • Locking down shape-shifting spike protein aids development of COVID-19 vaccine
  • COVID-19 vaccine innovation could dramatically speed up worldwide production

Regulatory Affairs

  • FDA issues Emergency Use Authorization for third COVID-19 vaccine
  • FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
  • EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
  • FDA takes additional action in fight against COVID-19 by issuing Emergency Use Authorization for second COVID-19 vaccine
  • Update on assessment of the BioNTech and Pfizer BNT162b2 vaccine marketing authorisation application
  1. You are here:  
  2. Home
  3. Research
  4. Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2021. All Rights Reserved.